Omalizumab in patients with chronic spontaneous urticaria: a systematic review and GRADE assessment.
about
A 63-year-old man with chronic spontaneous urticaria.Use of nonbiologic treatments in antihistamine-refractory chronic urticaria: a review of published evidence.Current and future therapies for treating chronic spontaneous urticaria.Efficacy of Treatment of Non-hereditary Angioedema.Patient-reported outcomes (PROs) in chronic urticaria.Immunoglobulin E-Mediated Autoimmunity.
P2860
Omalizumab in patients with chronic spontaneous urticaria: a systematic review and GRADE assessment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Omalizumab in patients with ch ...... c review and GRADE assessment.
@en
type
label
Omalizumab in patients with ch ...... c review and GRADE assessment.
@en
prefLabel
Omalizumab in patients with ch ...... c review and GRADE assessment.
@en
P2093
P2860
P356
P1476
Omalizumab in patients with ch ...... c review and GRADE assessment.
@en
P2093
A C Knulst
M C Urgert
M T van den Elzen
P2860
P304
P356
10.1111/BJD.13845
P407
P577
2015-04-18T00:00:00Z